UK markets closed

Beam Therapeutics Inc. (BEAM)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
47.64+0.14 (+0.29%)
At close: 04:00PM EDT
48.00 +0.36 (+0.76%)
After hours: 07:14PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 3.34B
Enterprise value 2.35B
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)42.21
Price/book (mrq)4.18
Enterprise value/revenue 30.60
Enterprise value/EBITDA -8.40

Trading information

Stock price history

Beta (5Y monthly) N/A
52-week change 3N/A
S&P500 52-week change 3N/A
52-week high 3100.06
52-week low 327.77
50-day moving average 358.09
200-day moving average 355.95

Share statistics

Avg vol (3-month) 31.22M
Avg vol (10-day) 31.18M
Shares outstanding 5N/A
Implied shares outstanding 6N/A
Float 8N/A
% held by insiders 1N/A
% held by institutions 1N/A
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 4N/A
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends N/A
Most-recent quarter (mrq)N/A

Profitability

Profit margin N/A
Operating margin (ttm)N/A

Management effectiveness

Return on assets (ttm)N/A
Return on equity (ttm)N/A

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)-180.29M
EBITDA N/A
Net income avi to common (ttm)N/A
Diluted EPS (ttm)N/A
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)N/A
Total cash per share (mrq)N/A
Total debt (mrq)N/A
Total debt/equity (mrq)N/A
Current ratio (mrq)N/A
Book value per share (mrq)N/A

Cash flow statement

Operating cash flow (ttm)N/A
Levered free cash flow (ttm)N/A